Skip to Main Content

Paper Details

The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy.
AIDS
0
2024
AIDS, ART, CD4, CD4+, CD4+ T-cell, CD4+ and, CD4+ and/or CD8+ T cells, CD8+, HIV, HIV-1, HIV-1 Gag, HIV-1 Gag conserved element, HIV-1 Gag conserved element vaccine, HIV-1 gag conserved element, HIV-1 gag conserved element DNA vaccine, PWH, RNA, T cells, conserved elements, full-length p55Gag, full-length p55Gag DNA vaccine, p24CE, p24CE DNA, p24CE DNA vaccine, p55Gag, p55Gag DNA, participants, people
Author NameAffiliation
Jeffrey M JacobsonCase Western Reserve University School of Medicine
Daniel R KuritzkesBrigham and Women's Hospital, Harvard Medical School
Daniel R KuritzkesBrigham and Women's Hospital, Harvard Medical School
Pablo TebasPerelman School of Medicine, University of Pennsylvania
David A WohlThe University of North Carolina School of Medicine
Margaret Juliana McElrathFred Hutchinson Cancer Research Center
  • 1 - 6

Datasets

Release 1.2